These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 27136447)

  • 1. Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients.
    Firouzjaei A; Li GC; Wang N; Liu WX; Zhu BM
    Nutr Diabetes; 2016 May; 6(5):e209. PubMed ID: 27136447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BO's abdominal acupuncture for obese type-2 diabetes mellitus].
    Yang Y; Liu Y
    Zhongguo Zhen Jiu; 2015 Apr; 35(4):330-4. PubMed ID: 26054139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin.
    Derosa G; Salvadeo SA; D'Angelo A; Fogari E; Ragonesi PD; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Arch Med Res; 2008 May; 39(4):412-9. PubMed ID: 18375253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bo's abdominal acupuncture improves disordered metabolism in obese type 2 diabetic rats through regulating fibroblast growth factor 21 and its related adipokines.
    Xihui Q; Jianli P; Guan X; Jie F
    J Tradit Chin Med; 2023 Oct; 43(6):1200-1208. PubMed ID: 37946482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy observation of acupuncture and tapping therapy in the treatment of type 2 diabetes of yin deficiency pattern combined with stasis in the patients].
    Wang YD; Liu ZC; Xu B
    Zhongguo Zhen Jiu; 2014 Aug; 34(8):731-5. PubMed ID: 25335242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents.
    Juárez-López C; Klünder-Klünder M; Madrigal-Azcárate A; Flores-Huerta S
    Pediatr Diabetes; 2013 Aug; 14(5):377-83. PubMed ID: 23438101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai.
    Chanchay S; Tungtrongchitr R; Harnroongroj T; Phonrat B; Rungseesakorn O; Paksanont S; Pooudong S; Saowakontha S; Varongchayakul C
    Int J Vitam Nutr Res; 2006 May; 76(3):125-31. PubMed ID: 17048191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
    Hansen D; Dendale P; Beelen M; Jonkers RA; Mullens A; Corluy L; Meeusen R; van Loon LJ
    Eur J Appl Physiol; 2010 Jun; 109(3):397-404. PubMed ID: 20131064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical observation on obesity and hyperlipidemia of liver qi stagnation and spleen deficiency pattern in female patients treated with combined therapy of acupuncture and tapping method].
    Wu B; Liu ZC; Xu B
    Zhongguo Zhen Jiu; 2014 Dec; 34(12):1151-5. PubMed ID: 25876338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
    Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
    Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
    Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
    J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
    Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
    Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial adiponectin levels are associated with improvements in postprandial triglycerides after Roux-en-Y gastric bypass in type 2 diabetic patients.
    Umeda LM; Pereira AZ; Carneiro G; Arasaki CH; Zanella MT
    Metab Syndr Relat Disord; 2013 Oct; 11(5):343-8. PubMed ID: 23745620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact on the lipid level of obesity of spleen deficiency and damp blockage complicated by hyperlipemia treated with warm needling therapy and auricular acupuncture].
    Wang K; Liu Z; Xu B
    Zhongguo Zhen Jiu; 2016 Mar; 36(3):225-30. PubMed ID: 27344822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.